In this observational study, researchers found that post-COVID-19 patients with telogen effluvium experienced varying hair loss and quality of life impacts, but no clear link was observed between this hair loss and vitamin D levels or quality of life.
This research addresses the common concern of hair loss, often seen in post-COVID syndrome and other systemic conditions, and highlights uncertainties around its causes, diagnostic criteria, and the necessity for medical consultation, with implications for patient psychological wellbeing.
19 citations
,
February 2023 in “Public Health” This study found that more than one-quarter of patients experienced persistent symptoms up to 24 months after mild COVID-19, suggesting long-term effects even in less severe cases.
February 2025 in “The Open Dermatology Journal” In this study conducted at Afzalipour Hospital in Iran, researchers found a significant prevalence of alopecia, particularly resembling telogen effluvium, among COVID-19-recovered patients, with hair loss being more common in females and correlating with arterial oxygen saturation levels.
October 2023 in “Journal of Preventive Diagnostic and Treatment Strategies in Medicine” This study found that women experiencing hair loss after recovering from COVID-19 had significantly lower Vitamin D and ferritin levels and higher testosterone and triglyceride levels compared to those without hair loss, indicating a potential link between these factors and the condition.
